TB

This guide provides an epidemiologic profile of TB in health care workers, as well as barriers in policy and practice, such as inadequate implementation of infection control.

This webinar provides an overview of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines and practical tips for implementation. Case studies are also presented.

This guide provides an overview of TB diagnostic tools and suggests recommendations for how activists and clinicians can contribute to improved TB diagnosis.

This document provides recommendations on the use chest radiography in TB detection. Specifically, the document provides information on chest radiography as a triage tool, diagnostic aid, and a screening tool. Additionally, quality assurance, safety, strategic planning, and technological developments are discussed.

The purpose of this toolkit is to assist TB programs in developing and implementing a TB eDOT program. Because eDOT programs can be very diverse to accommodate individual TB program needs, this toolkit provides general information that can be tailored to fit program needs.

The goal of this document is to provide practical answers to ethical questions in regard to the End TB Strategy.

This online course is designed to provide TB control staff, clinicians, and nurses a brief overview of basic principles of molecular technology and test platforms used for molecular testing of Mycobacterium tuberculosis as a basis for understanding how mutations are associated with drug resistance and what reporting language might be used to describe resistance results.

This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

This guide is intended to help health care providers use audiometry to make informed and patient-centered decisions to prevent and manage ototoxicity resulting from second-line anti-TB injectables.

This material is a collection of 45 examples of the prevention, control, and care of TB. There are examples from 21 countries, including 14 countries of high priority for MDR TB and countries with high and low TB incidence.